Escaping Pilot Purgatory: Scaling Digital Manufacturing From Proof of Concept to the Plant Floor

Scaling Pharma 4.0 digital manufacturing cannot be treated as a matter of extending a successful pilot across the plant. For pharmaceutical manufacturers, moving digital initiatives from proof of concept to production requires designing for validation, data governance, integration, and adoption from the outset, and governing the portfolio with the discipline to stop weak pilots early and advance strong ones quickly.

This white paper explores why pharmaceutical digital transformation initiatives stall in pilot purgatory and how to move them into production through production-ready pilot design, data architecture, risk-based Computer Software Assurance (CSA) for digital manufacturing validation, change management, realistic scale-up economics, and stage-gate portfolio governance. It also examines the current regulatory environment, including the FDA’s CSA guidance and the revision of EU Annex 11, and provides a practical roadmap for scaling digital manufacturing from proof of concept to the plant floor.

Fill out the form to receive our White Paper.